Drug-induced liver injury in 2007

W Norris, AH Paredes, JH Lewis - Current opinion in …, 2008 - journals.lww.com
The year 2007 brought with it several reminders of the importance of drug-induced liver
injury in the clinical trial as well as the clinical practice setting. There is additional evidence …

Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial …

M Maslov, S Foianini, M Lovich - Expert Opinion on Drug Delivery, 2017 - Taylor & Francis
Introduction: Local myocardial delivery (LMD) of therapeutic agents is a promising strategy
that aims to treat various myocardial pathologies. It is designed to deliver agents directly to …

Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro–in vivo extrapolation

EAH Algharably, E Di Consiglio, E Testai, R Kreutz… - Archives of …, 2021 - Springer
Amiodarone is an antiarrhythmic agent inducing adverse effects on the nervous system,
among others. We applied physiologically based pharmacokinetic (PBPK) modeling …

[PDF][PDF] Visual Disturbance in a Patient with Amiodarone Treatment Following Refractive Surgery

M Naser, SMM Shushtarian, A Shojaei… - … of Ophthalmic and …, 2017 - journals.sbmu.ac.ir
Amiodarone is an antiarrhythmic medication used to treat a number of irregular heartbeats.
Known ocular side effects of amiodarone include visual loss, swelling of the optic disc …

Permeabilized cryopreserved human hepatocytes as an exogenous metabolic system in a novel metabolism-dependent cytotoxicity assay for the evaluation of …

H Wei, AP Li - Drug Metabolism and Disposition, 2022 - ASPET
We report here a novel in vitro experimental system, the metabolism-dependent cytotoxicity
assay (MDCA), for the definition of the roles of hepatic drug metabolism in toxicity. MDCA …

[HTML][HTML] Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy

M Lahbabi, N Aqodad, A Ibrahimi… - World Journal of …, 2012 - ncbi.nlm.nih.gov
Amiodarone chlorhydrate is a diiodated benzofuran derivative used to treat cardiac rhythm
abnormalities. Hepatotoxicity is a relatively uncommon side effect of amiodarone and …

Assessing the risk for peripheral neuropathy in patients treated with dronedarone compared with that in other antiarrhythmics

C Wu, S Tcherny-Lessenot, W Dai, Y Wang… - Clinical …, 2018 - Elsevier
Purpose There are few data on the risk for peripheral neuropathy associated with
dronedarone, a newer antiarrhythmic medicine. The objective of this study was to assess …

[PDF][PDF] Gastrointestinal side effects of antiarrhythmic medications: a review of current literature

W Amjad, W Qureshi, A Farooq, U Sohail, S Khatoon… - Cureus, 2017 - cureus.com
Antiarrhythmic drugs are commonly prescribed cardiac drugs. Due to their receptor mimicry
with several of the gastrointestinal tract receptors, they can frequently lead to gastrointestinal …

Amiodarone‐Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports

P Kaur, A Kaur, A Sinha, W Khaliq… - The Journal of …, 2023 - Wiley Online Library
Amiodarone is an antiarrhythmic drug with a significant adverse effect profile, including
neurotoxicity. While ataxia, neuropathy, and tremors are more commonly seen forms of …

[HTML][HTML] The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice

HL Kim, JB Seo, WY Chung, SH Kim… - The Korean Journal of …, 2014 - ncbi.nlm.nih.gov
Methods Between January 1, 2000 and March 10, 2012, a total of 930 consecutive patients
who had been treated with amiodarone for arrhythmia were reviewed retrospectively. An …